318 related articles for article (PubMed ID: 1988704)
1. Analysis of alterations in the retinoblastoma gene and tumor grade in bone and soft-tissue sarcomas.
Wunder JS; Czitrom AA; Kandel R; Andrulis IL
J Natl Cancer Inst; 1991 Feb; 83(3):194-200. PubMed ID: 1988704
[TBL] [Abstract][Full Text] [Related]
2. Amplification of the CDK4 gene in sarcomas: tumor specificity and relationship with the RB gene mutation.
Kanoe H; Nakayama T; Murakami H; Hosaka T; Yamamoto H; Nakashima Y; Tsuboyama T; Nakamura T; Sasaki MS; Toguchida J
Anticancer Res; 1998; 18(4A):2317-21. PubMed ID: 9703873
[TBL] [Abstract][Full Text] [Related]
3. Involvement of the retinoblastoma gene in primary osteosarcomas and other bone and soft-tissue tumors.
Araki N; Uchida A; Kimura T; Yoshikawa H; Aoki Y; Ueda T; Takai S; Miki T; Ono K
Clin Orthop Relat Res; 1991 Sep; (270):271-7. PubMed ID: 1884549
[TBL] [Abstract][Full Text] [Related]
4. Some retinoblastomas, osteosarcomas, and soft tissue sarcomas may share a common etiology.
Weichselbaum RR; Beckett M; Diamond A
Proc Natl Acad Sci U S A; 1988 Apr; 85(7):2106-9. PubMed ID: 3162593
[TBL] [Abstract][Full Text] [Related]
5. Alterations of retinoblastoma susceptible gene accompanied by c-myc amplification in human bone and soft tissue tumors.
Ozaki T; Ikeda S; Kawai A; Inoue H; Oda T
Cell Mol Biol (Noisy-le-grand); 1993 Mar; 39(2):235-42. PubMed ID: 8513277
[TBL] [Abstract][Full Text] [Related]
6. Studies of the retinoblastoma gene in human sarcomas.
Reissmann PT; Simon MA; Lee WH; Slamon DJ
Oncogene; 1989 Jul; 4(7):839-43. PubMed ID: 2755701
[TBL] [Abstract][Full Text] [Related]
7. Molecular and immunohistochemical identification of p53 alterations in bone and soft tissue sarcomas.
Mousses S; McAuley L; Bell RS; Kandel R; Andrulis IL
Mod Pathol; 1996 Jan; 9(1):1-6. PubMed ID: 8821948
[TBL] [Abstract][Full Text] [Related]
8. Alterations of the p53, Rb and MDM2 genes in osteosarcoma.
Miller CW; Aslo A; Won A; Tan M; Lampkin B; Koeffler HP
J Cancer Res Clin Oncol; 1996; 122(9):559-65. PubMed ID: 8781571
[TBL] [Abstract][Full Text] [Related]
9. CDKN2A gene deletions and loss of p16 expression occur in osteosarcomas that lack RB alterations.
Nielsen GP; Burns KL; Rosenberg AE; Louis DN
Am J Pathol; 1998 Jul; 153(1):159-63. PubMed ID: 9665476
[TBL] [Abstract][Full Text] [Related]
10. Mutation of the p53 gene in human soft tissue sarcomas: association with abnormalities of the RB1 gene.
Stratton MR; Moss S; Warren W; Patterson H; Clark J; Fisher C; Fletcher CD; Ball A; Thomas M; Gusterson BA
Oncogene; 1990 Sep; 5(9):1297-301. PubMed ID: 2216456
[TBL] [Abstract][Full Text] [Related]
11. Expression of the mdr1 gene in bone and soft tissue sarcomas of adult patients.
Stein U; Wunderlich V; Haensch W; Schmidt-Peter P
Eur J Cancer; 1993; 29A(14):1979-81. PubMed ID: 7904171
[TBL] [Abstract][Full Text] [Related]
12. Genetic and molecular abnormalities in tumors of the bone and soft tissues.
Letson GD; Muro-Cacho CA
Cancer Control; 2001; 8(3):239-51. PubMed ID: 11378650
[TBL] [Abstract][Full Text] [Related]
13. Mutation spectrum of the p53 gene in bone and soft tissue sarcomas.
Toguchida J; Yamaguchi T; Ritchie B; Beauchamp RL; Dayton SH; Herrera GE; Yamamuro T; Kotoura Y; Sasaki MS; Little JB
Cancer Res; 1992 Nov; 52(22):6194-9. PubMed ID: 1423262
[TBL] [Abstract][Full Text] [Related]
14. MDM2 gene amplification in bone and soft-tissue tumors: association with tumor progression in differentiated adipose-tissue tumors.
Nakayama T; Toguchida J; Wadayama B; Kanoe H; Kotoura Y; Sasaki MS
Int J Cancer; 1995 Oct; 64(5):342-6. PubMed ID: 7591308
[TBL] [Abstract][Full Text] [Related]
15. p53 expression and its relationship to DNA alterations in bone and soft tissue sarcomas.
Wadayama B; Toguchida J; Yamaguchi T; Sasaki MS; Yamamuro T
Br J Cancer; 1993 Dec; 68(6):1134-9. PubMed ID: 8260365
[TBL] [Abstract][Full Text] [Related]
16. Changing concepts in the pathological basis of soft tissue and bone sarcoma treatment.
Hogendoorn PC; Collin F; Daugaard S; Dei Tos AP; Fisher C; Schneider U; Sciot R;
Eur J Cancer; 2004 Jul; 40(11):1644-54. PubMed ID: 15251152
[TBL] [Abstract][Full Text] [Related]
17. p53 gene gets altered by various mechanisms: studies in childhood sarcomas and retinoblastoma.
Ghule P; Kadam PA; Jambhekar N; Bamne M; Pai S; Nair C; Banavali S; Puri A; Agarwal M
Med Sci Monit; 2006 Dec; 12(12):BR385-396. PubMed ID: 17136003
[TBL] [Abstract][Full Text] [Related]
18. [Alterations of retinoblastoma gene and its protein expression in aggressive bone tumors].
Li Y; Qiu J
Zhonghua Bing Li Xue Za Zhi; 1997 Oct; 26(5):262-5. PubMed ID: 10374331
[TBL] [Abstract][Full Text] [Related]
19. Altered patterns of retinoblastoma gene product expression in adult soft-tissue sarcomas.
Karpeh MS; Brennan MF; Cance WG; Woodruff JM; Pollack D; Casper ES; Dudas ME; Latres E; Drobnjak M; Cordon-Cardo C
Br J Cancer; 1995 Oct; 72(4):986-91. PubMed ID: 7547254
[TBL] [Abstract][Full Text] [Related]
20. Single nucleotide polymorphism in fibroblast growth factor receptor 4 at codon 388 is associated with prognosis in high-grade soft tissue sarcoma.
Morimoto Y; Ozaki T; Ouchida M; Umehara N; Ohata N; Yoshida A; Shimizu K; Inoue H
Cancer; 2003 Nov; 98(10):2245-50. PubMed ID: 14601095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
